Literature DB >> 7833907

Non-disjunction of chromosome 21 in maternal meiosis I: evidence for a maternal age-dependent mechanism involving reduced recombination.

S L Sherman1, M B Petersen, S B Freeman, J Hersey, D Pettay, L Taft, M Frantzen, M Mikkelsen, T J Hassold.   

Abstract

Over 300 cases of trisomy 21 were analyzed to characterize the causes of maternal non-disjunction and to evaluate the basis for maternal age-dependent trisomy 21. We confirmed the observation that recombination along 21q is reduced among non-disjoined chromosomes 21 and further demonstrated that the alterations in recombination are restricted to meiosis I origin. Analysis of the crossover distribution indicates that reduction in recombination is not due simply to failure of pairing and/or absence of recombination in a proportion of cases. Instead, we observed an increase in both zero- and one-exchange events among trisomy 21-generating meioses suggesting that an overall reduction in recombination may be the underlying cause of non-disjunction. Lastly, we observed an age-related reduction in recombination among the meiosis I cases, with older women having less recombination along 21q than younger women. Thus, reduced genetic recombination may be responsible, at least in part, for the association between advancing maternal age and trisomy 21.

Entities:  

Mesh:

Year:  1994        PMID: 7833907     DOI: 10.1093/hmg/3.9.1529

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  43 in total

1.  Replication asynchrony increases in women at risk for aneuploid offspring.

Authors:  A Amiel; O Reish; E Gaber; I Kedar; R Diukman; M Fejgin
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

2.  Patterns of meiotic recombination in human fetal oocytes.

Authors:  Charles Tease; Geraldine M Hartshorne; Maj A Hultén
Journal:  Am J Hum Genet       Date:  2002-05-01       Impact factor: 11.025

3.  Molecular analysis of nondisjunction in mice heterozygous for a Robertsonian translocation.

Authors:  Lara A Underkoffler; Laura E Mitchell; A Russell Localio; Shannon M Marchegiani; Justin Morabito; Joelle N Collins; Rebecca J Oakey
Journal:  Genetics       Date:  2002-07       Impact factor: 4.562

4.  Obligate short-arm exchange in de novo Robertsonian translocation formation influences placement of crossovers in chromosome 21 nondisjunction.

Authors:  Sue Ann Berend; Scott L Page; William Atkinson; Christopher McCaskill; Neil E Lamb; Stephanie L Sherman; Lisa G Shaffer
Journal:  Am J Hum Genet       Date:  2002-12-23       Impact factor: 11.025

5.  Heterochromatin-mediated association of achiasmate homologs declines with age when cohesion is compromised.

Authors:  Vijayalakshmi V Subramanian; Sharon E Bickel
Journal:  Genetics       Date:  2009-02-09       Impact factor: 4.562

6.  TroX: a new method to learn about the genesis of aneuploidy from trisomic products of conception.

Authors:  Amir R Kermany; Laure Segurel; Tiffany R Oliver; Molly Przeworski
Journal:  Bioinformatics       Date:  2014-03-21       Impact factor: 6.937

7.  Sex ratio in normal and disomic sperm: evidence that the extra chromosome 21 preferentially segregates with the Y chromosome.

Authors:  D K Griffin; M A Abruzzo; E A Millie; E Feingold; T J Hassold
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

8.  Meiotic recombination at the ends of chromosomes in Saccharomyces cerevisiae.

Authors:  Arnold B Barton; Michael R Pekosz; Rohini S Kurvathi; David B Kaback
Journal:  Genetics       Date:  2008-06-18       Impact factor: 4.562

Review 9.  Noninvasive prenatal testing: the future is now.

Authors:  Errol R Norwitz; Brynn Levy
Journal:  Rev Obstet Gynecol       Date:  2013

10.  Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study.

Authors:  P W Yoon; S B Freeman; S L Sherman; L F Taft; Y Gu; D Pettay; W D Flanders; M J Khoury; T J Hassold
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.